Skip to main content
. Author manuscript; available in PMC: 2013 Sep 6.
Published in final edited form as: Cancer Discov. 2012 Sep 6;2(9):798–811. doi: 10.1158/2159-8290.CD-12-0112

Figure 3. PARP1 protein expression in lung tumors.

Figure 3

(A) Total PARP expression was higher in neuroendocrine tumors (SCLC, LCNEC, atypical carcinoid, and typical carcinoid) than in lung squamous cell carcinoma and adenocarcinoma. ‡p=0.0002 (SCLC versus squamous tumors), †p=0.001 (LCNEC versus squamous), *p<0.0001 (SCLC or LCNEC compared to adenocarcinoma). (B) Representative PARP1 IHC staining for each tumor type.